NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10939	Companies
238877	Keywords
167702	Articles
128395	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 06/10/2025 at 22:20, 1 year 2 months ago

Number of Shares and Voting Rights of Nanobiotix

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/10/2025 at 22:15, 1 year 2 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle des droits de vote et actions de Nanobiotix, société de biotechnologie en phase clinique et avancée cotée sur Euronext Paris et le Nasdaq. Informations détaillées sur www.nanobiotix.com

Euronext Paris Biotechnologie Nasdaq NANOBIOTIX Physique
PRESS RELEASE

published on 06/10/2025 at 22:15, 1 year 2 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info

Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF

published on 05/21/2025 at 22:20, 1 year 3 months ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
BRIEF

published on 05/21/2025 at 22:20, 1 year 3 months ago

Nanobiotix publie ses résultats et sa situation financière pour le premier trimestre 2025

Biotechnologie Mise À Jour Financière NANOBIOTIX JNJ-1900 Essais Sur Le Cancer
PRESS RELEASE

published on 05/21/2025 at 22:15, 1 year 3 months ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Nanobiotix provides operational and financial update for Q1 2025, including CONVERGE study dosing, financial strengthening, and €39.8M cash reserves as of March 31, 2025

Operational Update Financial Update Cash Reserves NANOBIOTIX CONVERGE Study
PRESS RELEASE

published on 05/21/2025 at 22:15, 1 year 3 months ago

Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
Nanobiotix annonce ses progrès opérationnels et sa trésorerie pour le premier trimestre 2025, avec un renforcement financier et des avancées dans le traitement du cancer du poumon

Trésorerie Études Cliniques NANOBIOTIX Cancer Du Poumon JNJ-1900
BRIEF

published on 04/14/2025 at 22:20, 1 year 4 months ago

Nanobiotix : Mise à jour mensuelle des droits de vote et actions

Droits De Vote Euronext Capital Social Nasdaq NANOBIOTIX
BRIEF

published on 04/14/2025 at 22:20, 1 year 4 months ago

Nanobiotix: Monthly update of voting rights and shares

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 04/14/2025 at 22:15, 1 year 4 months ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Communiqué de presse mensuel sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations boursières et financières détaillées. Présentation de l'entreprise et de ses activités

Innovation Euronext Paris Droits De Vote Biotechnologie NANOBIOTIX

Accesswire

Published on 09/05/2026 at 04:05, 2 days 4 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 8 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 9 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 9 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 17 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 08:00, 21 minutes ago

Cairn Homes Plc: Transaction in Own Shares
Published on 09/07/2026 at 08:00, 21 minutes ago

£175m first close of Molten Ventures Growth Fund with cornerstone commitment from British Business Bank
Published on 09/07/2026 at 07:30, 51 minutes ago

Hannover Re sees profitable growth opportunities in an increasingly challenging market environment
Published on 09/07/2026 at 07:00, 1 hour 21 minutes ago

Swiss Re sees growing protection needs as risks become more complex and interconnected
Published on 09/07/2026 at 07:00, 1 hour 21 minutes ago

Half-year results for 2026 show a further increase

Les Echos

Published on 09/04/2026 at 18:57, 2 days 13 hours ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 13 hours ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 2 days 14 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026

View all LES ECHOS COMFI WIRE